Skip to main content
Last Updated
Case Status
Federal Trade Commission, Plaintiff, v. Neora, LLC, formerly known as Nerium International, LLC, a Texas limited liability company; Signum Biosciences, Inc., a Delaware corporation; Signum Nutralogix, a Delaware corporation and subsidiary of Signum Biosciences, Inc.; Jeffrey Olson; Maxwell Stock; and Jeffry Stock, Defendants.
FTC Matter/File Number
162 3099
Federal Court
District of New Jersey

Case Summary

The Federal Trade Commission sued the multi-level marketer Neora, LLC, formerly known as Nerium International, LLC, and its Chief Executive Officer, Jeffrey Olson, alleging that the company operates as an illegal pyramid scheme and falsely promises recruits they will achieve financial independence if they join the scheme. The lawsuit also alleges that defendants deceptively promote “EHT” supplements as an antidote to concussions and chronic traumatic encephalopathy caused by repetitive brain trauma, as well as Alzheimer’s disease and Parkinson’s disease. The FTC is seeking to permanently stop the defendants’ deceptive practices and return money to consumers.